July 24, 2019
by Jacob LaPorte
Biopharma insight
In a seminal work published by McKinsey & Company – The Granularity of Growth, a detailed study of the performance …
May 27, 2019
by David Shlaes
Biopharma insight
Over the past decade, pull incentives as a solution to the broken antibiotic market have been proposed to entice companies …
April 25, 2019
by Tim Sandle
Biopharma insight
Major companies on the scene include Second Genome, Enterome, and EpiBiome. In addition, several new startups have entered the field. …
Feb. 20, 2019
by Andrii Buvailo
Biopharma insight
In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” …
Dec. 27, 2018
by David Shlaes
Biopharma insight
Antibiotic R&D has had a particularly bad year starting with The Medicines Company who abandoned their antibiotic R&D efforts and …
Dec. 19, 2018
by Andrii Buvailo
Biopharma insight
Over the last five years the interest of pharmaceutical professionals towards machine learning (ML) and artificial intelligence (AI) has measurably …
Sept. 27, 2018
by Andrii Buvailo
Biopharma insight
What is a super-platform? A “super-platform” is a term which describes a relatively new phenomenon in a modern technological world …
Sept. 12, 2018
by Andrii Buvailo
Biopharma insight
Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry …
July 17, 2018
by Dr. Gerald J. Yakatan
Biopharma insight
China has been becoming a research powerhouse in many fields of science, but it still is a minor player when …
June 2, 2018
by Andrii Buvailo
Biopharma insight
(Edited version of this post originally appeared in Forbes) “It is not the strongest of the species that survives, nor …
April 25, 2018
by Andrii Buvailo, Alfred Ajami
Biopharma insight
Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate …
March 15, 2018
by Andrii Buvailo
Biopharma insight
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate …